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Abstract
Background: Type 2 Diabetes (T2D) and other chronic diseases are caused by a complex combination of many genetic and
environmental factors. Few methods are available to comprehensively associate specific physical environmental factors with
disease. We conducted a pilot Environmental-Wide Association Study (EWAS), in which epidemiological data are
comprehensively and systematically interpreted in a manner analogous to a Genome Wide Association Study (GWAS).
Methods and Findings: We performed multiple cross-sectional analyses associating 266 unique environmental factors with
clinical status for T2D defined by fasting blood sugar (FBG) concentration $126 mg/dL. We utilized available Centers for
Disease Control (CDC) National Health and Nutrition Examination Survey (NHANES) cohorts from years 1999 to 2006. Within
cohort sample numbers ranged from 503 to 3,318. Logistic regression models were adjusted for age, sex, body mass index
(BMI), ethnicity, and an estimate of socioeconomic status (SES). As in GWAS, multiple comparisons were controlled and
significant findings were validated with other cohorts. We discovered significant associations for the pesticide-derivative
heptachlor epoxide (adjusted OR in three combined cohorts of 1.7 for a 1 SD change in exposure amount; p,0.001), and
the vitamin c-tocopherol (adjusted OR 1.5; p,0.001). Higher concentrations of polychlorinated biphenyls (PCBs) such as
PCB170 (adjusted OR 2.2; p,0.001) were also found. Protective factors associated with T2D included b-carotenes (adjusted
OR 0.6; p,0.001).
Conclusions and Significance: Despite difficulty in ascertaining causality, the potential for novel factors of large effect
associated with T2D justify the use of EWAS to create hypotheses regarding the broad contribution of the environment to
disease. Even in this study based on prior collected epidemiological measures, environmental factors can be found with
effect sizes comparable to the best loci yet found by GWAS.
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Introduction
It is becoming clear that most non-communicable diseases are a
result of a complex combination of genetic processes and the
environment [1]. Despite the contribution of both genetics and
environment to disease, many recent studies have emphasized the
genetic components. For example, the Genome-wide Association
Study (GWAS) is a low-cost and popular framework used by
researchers to evaluate genetic factors that correlate with disease
status on a genome-wide scale [2]. As of this writing, 370
publications using this method have been cataloged, with 16 just
for Type 2 Diabetes Mellitus (T2D) [3]. Multiple loci markers have
been found through these studies that heightens risk for T2D when
present [4]. While GWAS has enabled the generation of new
hypotheses regarding the relation of genetics to T2D, the genetic
markers found have poor penetrance [5,6]. Further, these genetic
markers do not explain a significant portion of T2D in context of
other factors [7,8].
Perhaps the lack of impact of GWAS comes from not
comprehensively considering environmental factors in disease.
T2D provides an specific example: while genetics play a large role
[9–11], specific environmental factors are also emerging as risk
factors for the disease [12]. It is clear that we need to measure and
assess both types of factors to better understand complex disease
[1].
The current paradigm to search for the effects of multiple
environmental chemicals utilizes molecular tools and model
systems [13,14]; however, there is a gap between these data and
human disease. Epidemiological searches for environmental
factors associated with disease have been hampered by the lack
of a ‘‘chip’’ or standard bioassays that can broadly survey these
factors. We propose borrowing the GWAS methodology to create
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search for environmental factors associated with disease on a
broad scale. This type of study is made possible by the use of cross-
sectional epidemiological data, the National Health and Nutrition
Examination Survey (NHANES), a nationally representative,
biannual health survey conducted by the Centers For Disease
Control and Prevention (CDC) [15]. Participants are queried
regarding their health status and an extensive battery of clinical
and laboratory tests are performed on a subset of these individuals.
Specific environmental attributes are assayed, such as chemical
toxicants, pollutants, allergens, bacterial/viral organisms, and
nutrients.
The EWAS consists of two methodological steps that have
analogs in a GWAS. First, we consider a panel of 266 unique
environmental assays, or environmental ‘‘loci’’, measured across
cases of diabetics and controls, yielding several environmental
factors with significantly high association with T2D while
controlling for multiple hypotheses. Second, we validate the
associations by taking advantage of data from other cohorts in
NHANES. With EWAS, we are able to hypothesize about new
associations with T2D and reconfirm others. The results from
EWAS can better inform about environmental factors that need to
be measured in genetic studies to begin to provide us insight in
regards to disease etiology.
Methods
Ethics Statement
The NHANES is a publicly available dataset made available by
the CDC and National Centers for Health Statistics and all
participants have provided written consent.
We associate 266 unique environmental factors with T2D status
from the NHANES. We downloaded the all of the available
NHANES data for 1999–2000, 2001–2002, 2003–2004, and
2005–2006 cohorts and collated corresponding variables across
them. For example, if a variable with symbol LBXVIE from 1999–
2000 described ‘‘A-Tocopherol ug/dL’’ and variable with symbol
LBXATC from 2001–2002 also described ‘‘a-tocopherol ug/dL’’,
we harmonized onto the single symbol for both, LBXATC.
Figure 1 presents a schematic representation of our analysis
methodology. We analyzed all environmental factors from the
NHANES that were a direct measurement of an environmental
attribute, such as the amount of pesticide or heavy metal present in
urine or blood. We did not consider internal biological system
laboratory measures such as red blood cell count, triglyceride level,
cholesterol level, or other physiological measures. By using direct
and quantitative measures of factors, we potentially avoid issues of
self-report bias.
There was a total of 543 factors in our EWAS, but not all factors
were present in all cohorts: 111 factors measured in the 1999–
2000 cohort, 146 from 2001–2002, 211 from 2003–2004, and 75
from 2005–2006. This comprised of 266 unique environmental
factors in total, with 157 factors measured in more than one
cohort. Using NHANES categorization, we binned factors into 21
‘‘class’’ groupings in order to discern patterns among related
groups of factors, analogous to chromosomal units in GWAS
(Figure 1A). Different environmental factors were measured in
varying numbers of participants, ranging from 507 to 3318
individuals over the different environmental factors.
We omitted from our EWAS 73 factors that varied little across
individuals in our sample. Specifically, we omitted those that had a
majority (.90%) of the observations below a detection limit
threshold as defined by in the NHANES codebook. We also
removed factors that targeted a subset of the population, such as
the test for Trichomonas vaginalis, an infectious pathogen found
primarily in women.
T2D cases were individuals who had a fasting blood glucose
(FBG) level greater or equal to 126 mg/dL, as advised by the
American Diabetes Association (ADA) [16] (Figure 1B). We chose
specificity and accuracy of diagnosis over sensitivity, as we
acknowledge this definition ignores those who were previously
diagnosed as diabetic, but now keep their blood glucose under
tight control; in fact, a larger proportion of NHANES respondents
described themselves as diabetics or were taking medications often
used to treat diabetes than were classified by FBG levels. Neither
FBG nor the self-reported diabetes status distinguishes between
Type 1 Diabetes (T1D) and T2D; as T2D has a prevalence rate
more than 40 times higher than T1D, we assumed all our cases
have T2D. This claim is further justified given the average age of
the participants considered were between 41 and 42 years of age
for all cohorts.
We used survey-weighted logistic regression to associate each of
the 543 environmental attributes with diabetes status while
adjusting for age, sex, body mass index (BMI), ethnicity, and an
estimate for SES (Figure 1C). We acknowledge that estimating
SES is difficult; nevertheless, we used the tertile of poverty index,
equivalent to the participant’s household income divided by the
time-adjusted poverty threshold, as the estimate for SES. We used
R with the survey module to conduct all survey-weighted analyses,
and replicated our results with the STATA program [17–19].
Exposures were captured either as continuous or a categorical
variable. Most chemical exposure data arising from mass
spectrometry or absorption measurements occurred within a very
small range and had a right skew; thus, we log transformed these
variables. Further, we applied a z-score transformation (adjusting
each observation to the mean and scaling by the standard
deviation) in order to compare odds ratios from the many
regressions. Similarly, for categorical variables, we made the
definition of the referent consistent, defining them to be the
‘‘negative’’ results of the test.
We calculated the false discovery rate (FDR), the estimated
proportion of false discoveries made versus the number of real
discoveries made at a given significance level, to control for type I
error due to multiple hypotheses testing in associating the factors
to disease status [20]. To estimate the number of false discoveries,
we created a ‘‘null distribution’’ of regression test statistics by
shuffling the diabetes status labels 1000 times and recomputing the
regressions. The FDR was then estimated to be the ratio of the
proportion of results that were called significant at a given level a
in the null distribution and the proportion of results called
significant from our real tests. To choose factors significantly
associated with T2D in the first single-cohort phase, we used a
significance level (a=0.02), which corresponded to a FDR of 10%
across three out of four cohorts (1999–2000, 2003–2004, and
2005–2006) and 30% for the 2001–2002 cohort.
To improve our power, we used the four independent cohorts to
validate significant findings (Figure 1D). We considered a
significant factor as ‘‘validated’’ if it was found to be significant
(a=0.02) in more than one cohort, at the expense of having to
drop those factors not measured in a second cohort. We then
assessed the FDR of the multi-cohort validation. We first estimated
the number of false positives by counting the number of factors
found significant at a level a in two or more cohorts from the
permuted datasets. We then estimated the FDR by computing the
ratio between the number of false positives and the number of
validated factors. This value was 2% with a equal to 0.02.
We fit a final logistic regression model with data combined from
multiple NHANES cohorts utilizing all measurements for a
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PLoS ONE | www.plosone.org 2 May 2010 | Volume 5 | Issue 5 | e10746Figure 1. Summary of EWAS Environment Factors and Analytic Method. A.) Summary of the 21 factor classes and the number of factors
within them for each NHANES cohort. B.) Individuals were stratified into T2D status (‘‘cases’’ and ‘‘controls’’) through the ADA FBS threshold for
diabetes diagnosis. 6–7% of the unweighted observations in all cohorts had T2D under this rule. C.) Each of these 75 to 211 factors was tested for
association with T2D status with a logistic regression model (coefficient labeled ‘‘FACTOR’’) adjusted for age, sex, BMI, ethnicity, and SES. Statistical
significance (a=0.02) was determined by controlling the FDR between 10 to 30%. Between 4 and 23 factors were found to be significant using this
threshold a=0.02. D.) ‘‘Multi-stage’’ validation. For factors that were deemed significant in C, we deemed a factor validated if the factor was
significant to the a=0.02 level in one or more of the other cohorts. We found 5 factors to be validated (FDR of 2%).
doi:10.1371/journal.pone.0010746.g001
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covariates of the final model were age, sex, BMI, ethnicity, SES,
and cohort. We computed new sample weights for the combined
datasets by taking the average of the original sample weights as
described by the NHANES analytic guidelines [21].
We conducted 3 secondary analytic tests for the validity and
sensitivity of our final estimates. We first attempted to check for
reverse causality, or association of exposure due to T2D diagnosis.
Our second test attempted to take into account the lipophilic
characteristics of the environmental factors found. Our last test
attempted to take into account recent food and supplement
consumption as a potential bias for exposure measures. For
adequate sample size and ease of comparison to the final fit model,
we utilized all available data combining multiple NHANES
cohorts as the sample to conduct these three tests, described below.
To attempt to account for reverse causality, we recomputed our
models omitting those individuals who had been diagnosed with
diabetes, defined here as those answering yes answers submitted
on a NHANES health questionnaire (‘‘Doctor told you have
diabetes?’’). We then refit our final models with individuals only
showing biochemical evidence of T2D without actual diagnosis.
Our second test attempted to account for the lipophilic chemical
characteristics of our significant factors. Many of the environmen-
tal factors measured in NHANES absorb readily in fatty tissue;
presence of fatty tissue is also associated with T2D and a potential
confounder. Thus, we recomputed the models taking into account
total triglycerides and cholesterol measured in blood specimen of
participants.
In our third test, we attempted to compare dietary and
supplement consumption of cases or controls gathered from 24-
and 48-hour recall and supplement use questionnaires reasoning
that recent intake may confound exposure-disease association. The
NHANES data contains amount of food components consumed
based on the dietary recall available for all participants examined
above. Specifically, amounts of food components are computed
from the questionnaire using the United States Department of
Agriculture (USDA) Food and Nutrient Database. Some of the
vitamin and nutrient components included vitamin A, vitamin B-
6, vitamin B-12, vitamin C, vitamin E, vitamin K, carotenes,
lycopene, thiamin, riboflavin, niacin, folate, calcium, iron,
magnesium, phosphorus, potassium, sodium, iron, zinc, copper,
and selenium. Other components included macronutrients, such
as protein, carbohydrates, fat, fiber, and cholesterol. The total
amount of food components considered numbered 51 to 63 for the
different cohorts. Further, the 2003–2004 and 2005–2006 cohorts
contained both 24- and 48-hour recall data. Supplement use
included count of consumption of vitamins, minerals, botanicals,
and/or their mixture of them over the past month prior to the
survey. To check for possible confounding by recent consumption,
we added each food and supplement variable to the logistic
regression models specified above and re-evaluated significance
and effect size of the validated environmental factors. We coded
food component content as the logarithm (base 10) of the amount
entered. We coded supplement use as an integer count value. We
acknowledge the potential of bias with the use of questionnaire
data and a pre-determined database of food items but assumed it
was a reliable proxy of consumption and behavioral data in lieu of
other information.
Results
Using GWAS as inspiration, we systematically and comprehen-
sively assessed the association of 266 unique environmental factors
measured in the NHANES with T2D. Further, we validated these
associations by observing the significance of factors in other
NHANES cohorts.
Population characteristics
File S1 describes the baseline and demographic characteristics
of people who were considered as diabetics for our data. Across the
cohorts, the total non-weighted and weighted numbers of those
who were diabetic compared to non-diabetic were similar.
However, we did see significant differences with demographic
factors such as sex, age, and socioeconomic status between cases
and controls. T2D occurred in higher age groups in all cohorts
(p,0.001, two-sided t-test). There were significantly more male
participants than females in all cohorts (p,0.001, 0.02, 0.03, x
2
test) except for 2005–2006. Furthermore, there was a significant
association between lowest SES (first tertile of poverty index) and
T2D (p=0.006, 0.03, 0.04, logistic regression) in for the 1999–
2000, 2001–2002, and 2005–2006 cohorts respectively. While we
did not see a univariate association between ethnicity and T2D as
diagnosed by FBG, we did confirm previously reported associa-
tions of ethnicity with T2D when stratifying by age and sex [22].
As expected, BMI was significantly associated with T2D status
(p,0.001, t-test) for all cohorts. Given these differences between
the cases and controls, we adjusted our logistic regression models
described below accordingly.
Environment Associations with T2D
Figure 2 shows the distribution of p-values of association for
each environmental factor and class, adjusted for sex, age, BMI,
ethnicity, and the estimate for SES, plotted in a ‘‘Manhattan plot’’
analogous to the association results from a GWAS study. The 37
significant or notable factors are annotated in the figure. Specific
categories show association with T2D, such as organochlorine
pesticides, nutrients/vitamins, polychlorinated biphenyls, and
dioxins (Figure 2 and Table S1), having between 10 to 30% of
the factors in the class with p-values less than 0.02. Many positive
(low p-values) and negative (high p-values) associations replicated
well among the different cohorts.
Table 1 shows those factors that were validated as being
significant in two or more of the independent cohorts (multi-cohort
validation FDR of 2%). Predicted probabilities of having T2D
were computed for a prototype participant, a 45 year old white
male with BMI of 27 (middle of the range for non-diabetics in the
NHANES sample) and from the middle SES, at high and low
exposure levels. For combined cohorts, the predicted probability
applies to a prototype participant from the 2005–2006 cohort. We
also computed the overall estimate by combining NHANES
cohort data in a final model additionally adjusted for cohort; the
predicted probabilities for these models were computed for a
prototype participant as defined above. We defined low exposure
as having a log transformed exposure level one standard deviation
lower than the transformed mean, and high exposure as having a
log transformed exposure level one standard deviation higher than
the transformed mean. For example, a 45-year-old male from the
1999–2000 cohort with high levels (0.09 ng/g) of heptachlor
epoxide has a 6% likelihood of being in our diabetes subset.
Figures S1, S2, S3, S4, and S5 show the distributions of raw
exposure levels per diabetes status.
Nutrients and Vitamins: Carotenes and c-tocopherol
Several vitamins were found to have levels inversely associated
with T2D. The first type included an antioxidant in the isoforms of
b-carotene (final adjusted odds ratio (OR) of 0.6; 95% confidence
interval (CI) 0.5–0.7; p,0.001). For the prototypical participant,
high levels of trans or cis b-carotene equated to a 9%
An EWAS to Type 2 Diabetes
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confirm the inverse association of b-carotenes seen in multiple
epidemiological studies in Saudi Arabia [23], among older people
[24], among Swedish men [25], and in an earlier NHANES III
cohort (pre-1999) [26], as well as another small study that showed
an inverse response between fasting glucose level and b-carotene
[27]. However, in a prospective case-control study b-carotene was
not significantly inversely associated with T2D [28]. Because T2D
is associated with reduced anti-oxidant defense, anti-oxidants, such
as carotenes, have been occasionally recommended as a therapy
[29]. However, the evidence of mitigation of T2D with these
vitamins as therapies has been negligible in clinical trials, including
women who are high risk of cardiovascular disease [30] or male
smokers [31].
We discovered a vitamin that increased risk for T2D.
Surprisingly, c-tocopherol, a form of vitamin E, was highly
significantly and positively associated with T2D (final adjusted OR
1.5; 95% CI 1.3–1.7; p,0.001) in two cohorts (adjusted OR of 1.8
Figure 2. ‘‘Manhattan plot’’ style graphic showing the environment-wide association with T2D. Y-axis indicates 2log10(p-value) of the
adjusted logistic regression coefficient for each of the environmental factors. Colors represent different environmental classes as represented in
Figure 1A. Within each environmental class, factors are arranged left to right in order from lowest to highest odds ratio (OR). Plot symbols represent
different cohorts: 1999–2000 (diamonds), 2001–2002 (square), filled dot (2003–2004), circle (2005–2006). Red horizontal line is 2log10(a)=1.8
(a=0.02). Validated factors significant in 2 or more NHANES cohorts are in bold face (a=0.02 in two or more cohorts, FDR of 2%) with larger plot
points. Other significant factors (a=0.02) are annotated with numeric label corresponding to the environmental factor class color key on the right.
Figure abbreviations: Validated factors: t-b-carotene: trans b-carotene; c-b-carotene: cis b-carotene; PCB170: 2,29,3,39,4,49,5-Heptachlorobiphenyl.
Group 1 (dioxins): 1-hxcdd: 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin; 2-hxcdd: 1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin. Group 2 (furans): OCDF:
1,2,3,4,6,7,8,9-Octachlorodibenzofuran. Group 3 (heavy metals): Ur: uranium; Sb: antimony; Pb: Lead. Group 4 (nutrients): tot-b-car: total b-carotene; a-
car: alpha-carotene; retnl: retinol; Vita. D: vitamin D; d-t: delta-tocopherol. Group 5 (organochlorine pestcides): DDE: dichlorodiphenyltrichlor-
oethylene. Group 6 (PCB): PCB169:3 , 3 9,4,49,5,59-hexachlorobiphenyl; PCB138:2 , 2 9,3,4,49,49,5-Hexachlorobiphenyl; PCB195:2 , 2 9,3,39,4,49,5,6-
Octachlorobiphenyl; PCB183: 2,29,3,4,49,59,6-Heptachlorobiphenyl; PCB199: 2,29,3,39,4,5,59,69-Octachlorobiphenyl; PCB178: 2,29,3,39,5,59,6-Heptachlor-
obiphenyl; PCB187: 2,29,3,49,5,59,6-Heptachlorobiphenyl; PCB180: 2,29,3,4,49,5,59-Heptachlorobiphenyl; PCB146: 2,29,3,49,5,59-Hexachlorobiphenyl;
PCB196: 2,29,3,4,49,5,59,6-Octachlorobiphenyl. Group 7 (bacteria): H2: Herpes Simplex 2; HSBA: Hepatitis B Surface Antibody.
doi:10.1371/journal.pone.0010746.g002
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and nearly significant in the two others (adjusted OR of 1.3 and
1.6; p=0.06 and 0.04 for 2001–2002 and 2005–2006 cohorts). For
the prototypical participant, low levels of the c-tocopherol equated
to a 7% improvement in risk (13% vs. 6%). To our knowledge, this
is a novel association between c-tocopherol and T2D.
Persistent Pollutants: Polychlorinated Biphenyls and
Organochlorine Pesticides
We found organochlorinated pesticides and polychlorinated
biphenyls (PCBs), both related pollutant factors, to be a highly
positively associated with T2D. Among the PCBs, we specifically
discovered PCB170 (2,29,3,39,4,49,5-Heptachlorobiphenyl; final
adjusted OR of 2.2; 95% CI 1.6–3.2; p,0.001). The effect sizes in
the individual cohorts for PCB170 were large (adjusted OR 2.3
and 4.5; p=0.02 and 0.01 for 1999–2000 and 2003–2004
cohorts). The models predicted up to 15% T2D risk for the
prototype participant, more than double the risk of those with low
concentrations of PCB170. The association between the class of
PCBs with T2D has been well described within Native American
[32], Japanese [33], Swedish [34], and Taiwanese [35] cohorts.
Heptachlor epoxide, an oxidation product of the organochlo-
rine pesticide heptachlor, was among the most highly associated
factor (final adjusted OR 1.7; 95% CI 1.3–2.1; p,0.001) in our
EWAS. The effect sizes in the individual cohorts were also large
(adjusted OR 3.2 and 1.9; p=0.002 and 0.01 for 1999–2000 and
2003–2004 cohorts). The predicted probability for the prototypical
participant with high levels of the pollutant was 7%, more than 2
times greater than those who had lower levels of this pollutant.
Secondary analysis to test validity of the final estimates
We then attempted to test the validity of our final estimates by
conducting 3 additional analytic tests. In the first test, we
attempted to consider the possibility of ‘‘reverse causality’’ or
differential exposure status due to T2D diagnosis. Second, we
attempted to assess the effect of potential confounding bias due to
the lipophilic characteristics on our final environmental factor
effect estimates. Third, we attempted to assess the effect of recent
nutrient and supplement consumption on our final effect estimates.
To consider T2D diagnosis as a modulator of exposure, we
removed all individuals who answered yes when questioned about
a past history of diabetes in the NHANES health questionnaire
(‘‘Doctor told you have diabetes?’’). We then recomputed the effect
of exposure, adjusted for age, sex, SES, ethnicity, BMI, and cohort
using the remaining individuals who showed biochemical evidence
of T2D, but not carrying a diagnosis of T2D (Table S2). For all
validated factors significant in more than 2 cohorts above (Table 1),
the estimates remained stable and statistically significant. The
effect size for Heptachlor Epoxide was marginally smaller with an
adjusted OR of 1.6 (95% CI 1.1–2.1; p=0.008). The adjusted OR
for PCB170 was also marginally smaller, 2.1 (95% CI 1.2–3.9;
p=0.02). The effect of c-tocopherol was larger, with an adjusted
OR of 1.8 (95% CI 1.3–2.2; p,0.001) and there was no change to
effect sizes of the carotenes (adjusted OR 0.6; 95% CI 0.5–0.7;
p,0.001). We concluded that there was not enough evidence to
support the phenomenon of reverse causality based on the effect
sizes estimated for those who were at risk for T2D.
We next attempted to account for potential confounding bias of
lipid levels. To assess the degree of possible confounding we refit
Table 1. Highly statistically significant environmental factors associated with T2D found in more than one NHANES cohort.
Environmental class
Environment
Factor Cohort
N{ T2D,
No T2D P OR (95% CI)
Factor Level
(Lo-Hi)
Predicted
Probability
(Lo-Hi)
Nutrients cis-b-carotene 2001–2002 211, 2852 0.01 0.6 (0.5–0.8) 0.4–1.4 ug/dL 0.12–0.05
2003–2004 207, 2698 0.002 0.63 (0.5–0.7) 0.4–1.9 0.13–0.06
2005–2006 186, 2425 0.02 0.6 (0.5–0.8) 0.4–1.6 0.15–0.06
2001–2006* 604, 7975 ,0.001 0.6 (0.5–0.7) 0.4–1.7 0.15–0.06
trans-b-carotene 2001–2002 211, 2854 0.01 0.6 (0.5–0.8) 5.1–27.2 ug/dL 0.13–0.05
2003–2004 207, 2698 0.002 0.7 (0.6–0.8) 4.8–24.7 0.13–0.06
2005–2006 203, 2701 0.004 0.6 (0.4–0.7) 4.8–29.0 0.16–0.06
2001–2006 * 621, 8253 ,0.001 0.6 (0.5–0.7) 4.9–27.0 0.15–0.06
c-tocopherol 1999–2000 146, 2091 0.02 1.8 (1.3–2.4) 107–360 ug/dL 0.03–0.09
2003–2004 207, 2698 0.01 1.6 (1.3–2.0) 103–356 0.06–0.13
1999–2006* 767, 10307 ,0.001 1.5 (1.3–1.7) 107–352 0.06–0.13
Organochlorine Pesticides Heptachlor Epoxide 1999–2000 46, 635 0.002 3.2 (2.4–4.4) 0.02–0.09 ng/g 0.01–0.06
2003–2004 67, 809 0.01 1.9 (1.3–2.6) 0.01–0.07 0.02–0.07
1999–2004* 178, 2367 ,0.001 1.7 (1.3–2.1) 0.02–0.08 0.03–0.07
Polychlorinated Biphenyls PCB170 1999–2000 45, 716 0.02 2.3 (1.5–3.6) 0.03–0.12 ng/g 0.01–0.06
2003–2004 53, 773 0.01 4.5 (2.1–9.9) 0.01–0.12 0.03–0.42
1999–2004* 165, 2426 ,0.001 2.2 (1.6–3.2) 0.02–0.13 0.04–0.15
Odds ratio for each exposure, adjusted for BMI, age, sex, ethnicity, and SES is calculated for a change in the log exposure level by one standard deviation, along with the
95% confidence interval. Factor level is the amount of exposure defined by the low (1 SD lower than the average logged exposure level) and high range (1 SD higher
than the average logged exposure level). The predicted probability range is an estimate for a 45-year-old white male with BMI of 27 kg/m
2 from the middle SES to
develop the disease in the low to high range of exposure.
* denotes analysis using combined NHANES cohorts; models adjusted for age, sex, ethnicity, BMI, SES, and cohort; predicted probabilities for combined cohorts applies
to an individual from the 2005–2006 cohort.
{denotes unweighted number.
doi:10.1371/journal.pone.0010746.t001
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triglyceride and cholesterol levels in addition to age, sex, BMI,
SES, ethnicity, and cohort (Table S3). We did not observe a great
change in effect sizes estimates for the environmental factors after
this further adjustment for total triglycerides and cholesterol. The
odds ratio after adjusting for lipid levels for carotenes was 14%
higher, 0.7 (95% CI 0.6–0.8; p,0.001) compared to 0.6 (Table 1).
Similarly, the odds ratio for c-tocopherol was attenuated by 7%,
1.4 (95% CI 1.2–1.6; p,0.001) compared to 1.5 (Table 1). For the
pesticide factor, the odds ratio was smaller by 6%, 1.6 (95% CI
1.3–2.0; p,0.001) versus 1.7 (Table 1). Lastly, for PCB factor, we
observed a 3% higher odds ratio of 2.3 (95% CI 1.4–3.7,
p=0.002) versus 2.2 (Table 1). Consistent with this secondary
analysis, we observed a similar degree of effect size differences
when using the ‘‘Lipid Adjusted’’ NHANES environmental
factors, which are only provided for few of the pollutant factors
(not shown). We concluded that the effect sizes of the
environmental factors were affected by lipid levels, but not
substantially biased by them.
We then searched for differences in food and supplement
consumption patterns between diabetics and non-diabetics for all 4
cohorts close to the time of survey derived from dietary recall and
supplement use questionnaires. In comparing dietary nutrients, we
did not observe a difference for any dietary nutrient except one
between cases and controls. This exception included a lower total
carbohydrate intake for diabetics versus controls, confirming that
many diabetics may have known about their disease; specifically,
the adjusted OR was 0.7 (95% CI 0.6–0.8; p=0.001) for a 10%
increase in total carbohydrate consumption, adjusted for sex, age,
ethnicity, SES, and cohort. We also observed an inverse
association between any supplement use and T2D, with an
adjusted OR of 0.6 (95% CI 0.5–0.8, p,0.001), also consistent
with our expectation of increased health awareness for those with
T2D. However, we specifically could find no difference in
consumption of carotenes or tocopherol (p=0.85 and 0.2
respectively) between cases and controls, two of the validated
nutrient factors found in our EWAS (Table 1).
Having observed some difference in consumption behavior
between cases and controls, we then attempted to assess the
influence of recalled dietary consumption on the environmental
associations by recomputing the logistic regression models in
presence of dietary and supplement use variables. Adding the new
dietary or supplementary vitamin consumption variables did not
attenuate the odds ratios (maximum change of 1–2%), nor did
they lessen the strength of the associations for all of the 5 validated
environmental factors described in Table 1. Thus, we did not have
evidence to support that recent consumption influenced the factor-
disease effect sizes for the validated factors found in our EWAS.
We took a further step in assessing the strength of the
environmental associations, adjusting for total triglycerides and
cholesterol, any supplement use, and food intake simultaneously
(Table S4). Specifically, the odds ratio for a SD increase in c-
tocopherol levels was 1.3 (95% CI 1.1–1.5; p=0.004) when
adjusting for logarithm base 10 of triglycerides, cholesterol, total
vitamin E consumption, beta carotene consumption, total
carbohydrate consumption, and any supplement use along with
age, sex, ethnicity, BMI, and SES. The analogous models for the
cis and trans b-carotene resulted in adjusted OR of 0.7 (95% CI
0.6–0.8; p,0.001). Odds ratios were consistently high and
significant for the pollutant factors Heptachlor Epoxide and
PCB170 after further analogous adjustment of recent consumption
and total lipid levels, with odds ratios of 1.6 (95% CI 1.3–2.1;
p,0.001) and 2.2 (95% CI 1.4–3.5; p=0.003) respectively (Table
S4). We concluded that recent consumption as encoded by the
dietary recall questionnaire in conjunction with lipid levels did not
alter the validity of the associations of the 5 environmental factors
found.
To summarize of our secondary tests for validity, we concluded
that reverse causality, recent food and supplement consumption,
and total lipid levels did not substantially bias our effect estimates
for the 5 validated factors. These tests were made possible by the
extensive list of co-variates available in the NHANES.
Discussion
We have described a prototype Environmental-Wide Associa-
tion Study (EWAS) and applied it to the study of Type 2 Diabetes
(T2D), and validated many of our significant findings across
independent cohorts and confirmed some of them through the
literature. This pilot study is made possible by the examination of
multiple cohorts present in the nationally representative NHANES
dataset. We have rediscovered factors such as carotenes and PCBs
with previously known association with T2D. Unexpectedly, we
found higher levels of c-tocopherol were associated with higher
likelihood of T2D, independent of dietary intake. Of the
components of Vitamin E, c-tocopherol is the most abundant
form in the US diet [36], and makes up to 50% of the total vitamin
E in human muscle and adipose tissue [37], two known insulin-
target tissues. As c-tocopherol has been previously suggested as a
preventive agent against colon cancer [38], any potential adverse
metabolic effects for this vitamin should be studied closely.
Another novel finding was in the significant association between
heptachlor epoxide levels and T2D. Heptachlor is a pesticide;
most uses of heptachlor were discontinued in the late 1980s [39].
The main source of heptachlor and its breakdown product,
heptachlor epoxide, is from food, but heptachlor epoxide is
persistent in the environment and can even be passed in breast
milk [40]. While a significant association with T2D has been
reported across thirty-thousand pesticide applicators who used the
pesticide heptachlor [41], to our knowledge, this broad association
between heptachlor epoxide and T2D in the general public, as
surveyed by NHANES, is novel.
While this study successfully demonstrates a prototype EWAS
for T2D, this methodology can be reconfigured to measure the
relationship between environmental factors and other disorders,
such as obesity, lipid level abnormalities, hypertension, and/or
cardiovascular disease. Methodologically, the EWAS takes inspi-
ration from GWAS, which have been used to assess the correlation
between genome-wide variability and disease.
Like GWAS, the utility of EWAS lies in two types of hypothesis
generation. First, the EWAS framework can be used to propose
targets for further study. For example, many factors are correlated;
some are similar structurally, such as the isomers of b-carotene, or
co-occur in the environment, such as the PCBs and organochlo-
rine pesticides. As we extend the GWAS analogy, these and other
environmental factors could be said to be in ‘‘linkage disequilib-
rium’’ with each other. Just as is done for preliminary GWAS
findings, EWAS findings can and should be used to identify further
factors that may be in ‘‘disequilibrium,’’ for further detailed
measurement and causal identification.
We acknowledge that the measurement of 266 environmental
factors is hardly a comprehensive study of the environment, but
this is still a greater number of factors measured than the 30
microsatellite markers [42], or 100 single nucleotide polymor-
phisms (SNPs) in some of the earliest implementations of GWAS
[43]. We suggest that measurement technologies for the
environment can and will improve in resolution, as novel
associations are made using even few measurements in these
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factors used here, most of which are performed by mass
spectrometry, currently costs an estimated $40,000 per individual
[44], or close to the current pricing for whole-genome sequencing.
Another type of hypothesis we may generate is regarding the
complex cause of disease. For example, we can now use an EWAS
to hypothesize about ‘‘gene-environment’’ interactions and their
relation to disease etiology. A future study addressing gene-
environment interactions might be designed as a combination of
both a GWAS and EWAS, where genetic variability is assessed
simultaneously along with key environmental factors. While
marginally more resource intensive, this type of study design
could perhaps facilitate an explanation of disease causation that
has eluded genomic-wide scans in addition and provide more
accurate estimates of attributable risk.
The EWAS allows for comprehensive and systematic analysis of
the effects of the environment in association with disease on a
broad scale. While many investigators have already utilized the
NHANES to address the effect of a limited number of factors on
disease, they do not provide a global view of these associations
[45,46]. Further, while arriving at similar results, the previous
studies use differing definitions of T2D status (medical question-
naire), exposure coding (discretization or log transformation), and
lack methods for multiple comparison control [47–49]. It is the
well-established toolkit of the GWAS that has provided us with
methods to overcome these limitations and to enable us to
postulate about environment-wide association with disease.
Limitations of this study remind us that measuring environ-
ment-wide aspects in relation to phenotypic states such as disease
will be a difficult undertaking [50]. Unlike genetic loci, the
environment is boundless. While the NHANES provides a large
number of factors to study, a comprehensive assessment will
require precise definition over a broader dimension (more factors).
While laboratory measurements are collected during a baseline
fasting state for all participants in NHANES, we will still have to
account for the dynamic and heterogeneous nature of different
exposures and their associated responses by taking replicate
measurements at different physiological states. Further, this study
utilizes cross-sectional data and can only show correlation between
exposure and disease prevalence. To ascertain causality, we would
need to perform prospective EWAS over the life course, consider
incident cases, and/or consider randomization methods [51] as
additional validation. Due to the number of hypotheses generated,
we would need to integrate more evidence from large-scale
collaborative studies in order to confirm (or refute) etiological
aspects of these factors while being as comprehensive as possible in
the observation of potential confounding variables. For example,
additional factors such as behavior (food consumption, drug use,
and/or exercise patterns), geographic location, and occupation
must also be ascertained to account for associated risk factors and
reverse causality.
While GWAS has allowed us to find novel variants associated
with T2D of possible mechanistic importance and provided a
model for a comprehensive study of the environment described
here, associated variants have had only moderate effect sizes to
date. Most of the risk loci identified with GWAS have small
individual odds ratios, generally less than 1.3 [52–54] and the
highest has been reported to be 1.71, belonging to a variant in the
TCF7L2 gene [55,56]. Albeit from different populations and
analytical scenarios, the effect sizes of our validated environmental
factors on T2D were comparable to the highest odds ratios seen in
GWAS.
However, the correlated and dynamic nature of a multitude of
environmental factors will hinder causal inference to a greater
degree than GWAS [50]. Nevertheless, similar biases do influence
GWAS interpretation. For example, the statistical association of a
variant of FTO with T2D was nullified by accounting for BMI
[57]. However, despite these hindrances, we view EWAS similarly
to GWAS, a step towards learning about a component that plays a
large role in complex disease.
It is imperative not only for epidemiologists and geneticists but
also physicians and their patients to understand how multiple
environmental factors may influence disease in a systematic
fashion. Individuals are already demanding information regarding
their ‘‘body burdens’’, or the number and amount of chemicals
present in their system, as evidenced by the ‘‘Human Toxome
Project’’ [44,58]. We must learn how all these factors might
contribute to disease in context of other common risk factors to
inform our health care practitioners and individuals appropriately.
We must conduct our analyses in a non-selective fashion.
In conclusion, the EWAS is a promising way to search and
consider potential environmental factors as associated with disease
or other clinical phenotypes. These results demand a rethinking
and restructuring of studies that study disease in the genomics
context. The time is ripe to usher in ‘‘enviromics’’ [59], the study
of a wide array of environmental factors in relation to health and
biology.
Supporting Information
File S1 The tables in this file describe the baseline demographics
of the NHANES cohorts (1999–2000, 2001–2002, 2003–2004,
2005–2006) per T2D status (Fasting Plasma Glucose .125 mg/
dL). T2D cases were determined by a clinical threshold of
$126 mg/dL fasting blood glucose. Unweighted total samples
were similar across cohorts. Age and BMI were significantly
different between each of groups and the proportion of sex was
significantly different in 3 of the 4 cohorts (male referent group).
Low, medium, and high estimates of SES were computed by tertile
of poverty index. Low SES (lowest tertile of poverty index) is also
associated with T2D status in 3 of the 4 cohorts (3rd tertile SES
referent group). Ethnicity was not seen to be associated with T2D
status (‘‘white’’ ethnicity referent group). * denotes unweighted
number. All other statistics are weighted.
Found at: doi:10.1371/journal.pone.0010746.s001 (0.09 MB
DOC)
Figure S1 Trans-b-carotene vs. Diabetes Status for 2001–2002,
2003–2004, and 2005–2006 cohorts. Raw exposure data (log-
scale) versus T2D Status (Fasting Plasma Glucose .125 mg/dL)
for validated environmental factors. Horizontal line represents the
weighted median of the group. Cohort plot symbols consistent
with Figure 2 (square: 2001–2002; filled bullet: 2003–2004; circle:
2005–2006).
Found at: doi:10.1371/journal.pone.0010746.s002 (1.17 MB
DOC)
Figure S2 Cis-b-carotene vs. Diabetes Status for 2001–2002,
2003–2004, 2005–2006 cohorts. Raw exposure data (log-scale)
versus T2D Status (Fasting Plasma Glucose .125 mg/dL) for
validated environmental factors. Horizontal line represents the
weighted median of the group. Cohort plot symbols consistent
with Figure 2 (square: 2001–2002; filled bullet: 2003–2004; circle:
2005–2006).
Found at: doi:10.1371/journal.pone.0010746.s003 (1.01 MB
DOC)
Figure S3 c-tocopherol vs. Diabetes Status for 1999–2000 and
2003–2004 cohorts. Raw exposure data (log-scale) versus T2D
Status (Fasting Plasma Glucose .125 mg/dL) for validated
An EWAS to Type 2 Diabetes
PLoS ONE | www.plosone.org 8 May 2010 | Volume 5 | Issue 5 | e10746environmental factors. Horizontal line represents the weighted
median of the group. Cohort plot symbols consistent with Figure 2
(diamond: 1999–2000; filled bullet: 2003–2004).
Found at: doi:10.1371/journal.pone.0010746.s004 (0.83 MB
DOC)
Figure S4 Heptachlor Epoxide vs. Diabetes Status for 1999–
2000 and 2003–2004 cohorts. Raw exposure data (log-scale) versus
T2D Status (Fasting Plasma Glucose .125 mg/dL) for validated
environmental factors. Horizontal line represents the weighted
median of the group. Cohort plot symbols consistent with Figure 2
(diamond: 1999–2000; filled bullet: 2003–2004).
Found at: doi:10.1371/journal.pone.0010746.s005 (0.49 MB
DOC)
Figure S5 PCB170 vs. Diabetes Status for 1999–2000 and
2003–2004 cohorts. Raw exposure data (log-scale) versus T2D
Status (Fasting Plasma Glucose .125 mg/dL) for validated
environmental factors. Horizontal line represents the weighted
median of the group. Cohort plot symbols consistent with Figure 2
(diamond: 1999–2000; filled bullet: 2003–2004).
Found at: doi:10.1371/journal.pone.0010746.s006 (0.50 MB
DOC)
Table S1 Percent of significant (p,0.02, FDR between 10 to
30%) environmental factors found by environmental class and
cohort in first stage of T2D association. Number found of total per
class is also shown in parentheses. * denotes that there were no
factors measured for that particular environmental class as of this
writing. There were a total of 21 environmental classes explored.
Found at: doi:10.1371/journal.pone.0010746.s007 (0.05 MB
DOC)
Table S2 Adjusted odds ratios for validated factors for
individuals at risk for T2D diagnosis. Individuals who answered
yes to having T2D in the NHANES questionnaire (‘‘Doctor told
you have diabetes?’’) were omitted from the sample, leaving only
those who were at risk for T2D diagnosis. Estimates were adjusted
for age, sex, BMI, SES, ethnicity, and cohort. Odds ratios are for a
change in 1SD of the logarithm of exposure in association with
T2D diagnosis risk.
Found at: doi:10.1371/journal.pone.0010746.s008 (0.03 MB
DOC)
Table S3 Adjusted odds ratios for validated factors, adjusting for
age, sex, BMI, SES, ethnicity, cohort, log10(total triglycerides),
log10(total cholesterol). Odds ratios are for a change in 1SD of the
logarithm of exposure in association with T2D.
Found at: doi:10.1371/journal.pone.0010746.s009 (0.03 MB
DOC)
Table S4 Adjusted odds ratios for validated factors, adjusting for
age, sex, BMI, SES, ethnicity, cohort, log10(triglycerides),
log10(total cholesterol), log10(total vitamin E consumption recall),
log10(total b-carotene consumption recall), log10(total carbohy-
drate consumption recall), supplement use (yes/no) . Odds ratios
are for a change in 1 SD of the logarithm of exposure in
association with T2D. * denotes models did not include b-carotene
as these data were not available for the 1999–2000 cohort.
Found at: doi:10.1371/journal.pone.0010746.s010 (0.03 MB
DOC)
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